Unrestricted availability of intracoronary stents is associated with decreased abrupt vascular closure rates and improved early clinical outcomes
- PMID: 11870931
- DOI: 10.1002/ccd.10013
Unrestricted availability of intracoronary stents is associated with decreased abrupt vascular closure rates and improved early clinical outcomes
Abstract
The purpose of this study was to determine whether the unrestricted availability of intracoronary stents is affecting abrupt vascular closure rates and early clinical outcomes. Intracoronary stents have improved procedural outcome despite their application in more complex lesions, but the impact of unrestricted availability of stents on abrupt closure and early clinical outcomes is unknown. Two cohorts were identified retrospectively from a coronary intervention registry: patients treated between 1988 and 1992 (n = 3,617) when stents were not generally available, and patients treated between 1994 and 1997 (n = 4,518) when stents were freely available. The late cohort patients consisted of more females; it also had greater comorbidity and more complex presentation. However, there was a significant reduction in the abrupt closure rates between the two time periods (7% vs. 4%, P < 0.0001). After adjusting for female gender, thrombus, and lesion angulation, the late cohort remained significantly associated with decreased odds of abrupt closure (odds ratio [OR] = 0.62, 95% upper and lower confidence intervals [CI] = 0.52-0.75, P = 0.0001). The late cohort also had decreased in-hospital mortality (OR = 0.91, CI = 0.86-0.95, P = 0.0002) and major adverse clinical event (OR = 0.93, CI = 0.91-0.96, P = 0.0001). Unrestricted availability of intracoronary stents is associated with reduced abrupt closure rates and improved early clinical outcomes among patients undergoing coronary intervention despite treatment of high-risk patients.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control study.J Am Coll Cardiol. 1993 Mar 15;21(4):866-75. doi: 10.1016/0735-1097(93)90341-w. J Am Coll Cardiol. 1993. PMID: 8450155
-
Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group.Circulation. 1994 Mar;89(3):1126-37. doi: 10.1161/01.cir.89.3.1126. Circulation. 1994. PMID: 8124799 Clinical Trial.
-
Adjunctive intracoronary dipyridamole in the interventional treatment of small coronary arteries: a prospectively randomized trial.Am Heart J. 2000 Jun;139(6):1039-45. doi: 10.1067/mhj.2000.106607. Am Heart J. 2000. PMID: 10827385 Clinical Trial.
-
Intracoronary stents: a new approach to coronary artery dilatation.J Cardiovasc Nurs. 1992 Oct;7(1):34-49. doi: 10.1097/00005082-199210000-00006. J Cardiovasc Nurs. 1992. PMID: 1447583 Review.
-
Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.Coron Artery Dis. 2010 Jan;21(1):46-56. doi: 10.1097/MCA.0b013e328333f550. Coron Artery Dis. 2010. PMID: 19952925 Review.
Cited by
-
Revascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials.Curr Cardiol Rep. 2012 Aug;14(4):468-76. doi: 10.1007/s11886-012-0274-x. Curr Cardiol Rep. 2012. PMID: 22638907 Review.
MeSH terms
LinkOut - more resources
Full Text Sources